£60.64

This is the usual price. Wait for it to drop, or tell us your number.

£61 today · usual range £54–£73 · best ever £54

Springer Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 56 days · 56 data points (no recent data)

Historical
Generating forecast…
£72.76 £51.72 £56.31 £60.90 £65.49 £70.08 £74.67 25 July 2026 07 August 2026 21 August 2026 04 September 2026 18 September 2026
View at Amazon ↗

Price data last checked 35 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 56 days • 7 price levels

Days at Price
Current Price
8 days 15 days 7 days 6 days · current 12 days 1 day 7 days 0 4 8 11 15 £54 £57 £59 £61 £64 £68 £73 Days at Price

Price Analysis

Most common price: £57 (15 days, 26.8%)

Price range: £54 - £73

Price levels: 7 different prices over 56 days

Description

In the last decade, the literature on molecular mechanisms and activated pathways in the different lymphoma categories increased exponentially, which was followed by a more diffuse and successful use of targeted therapies. In this book, expert authors revisit the most relevant aspects of these therapies, with special emphasis on molecular mechanisms and clinical effects of resistance. The knowledge of the underlying mechanisms involved in tumor resistance to target therapies is of paramount importance because they will result in a better selection of patients with sensitive disease and the establishment of suitable combinations of drugs that target different molecules and could overcome the established resistance.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
13 April 2018
Listed Since
09 January 2018

Barcode

No barcode data available

Similar Products You Might Like

Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)
97% match

Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

Springer

£74.43 22 Sep 2026
Aggressive Lymphomas (Hematologic Malignancies)
96% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£89.28 24 Sep 2026
Lymphoma: Methods and Protocols - Volume 971 Research Guide
96% match

Lymphoma: Methods and Protocols - Volume 971 Research Guide

Humana

£101.40 02 Oct 2026
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy
96% match

Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy

Springer

£108.01 03 Oct 2026
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
96% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£65.61 22 Sep 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
96% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£122.35 24 Sep 2026
Drug Resistance in Leukemia and Lymphoma III - Medical Reference
96% match

Drug Resistance in Leukemia and Lymphoma III - Medical Reference

Springer

£148.21 22 Sep 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
96% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£122.54 18 Sep 2026
Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)
96% match

Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)

CRC Press

£163.39 01 Oct 2026
Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy
96% match

Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Springer

£78.85 13 Sep 2026
Targeted Cancer Therapy: A Ha: A Handbook for Nurses
96% match

Targeted Cancer Therapy: A Ha: A Handbook for Nurses

Jones & Bartlett Learning

£116.40 18 Sep 2026
Radiotherapy for Hodgkin Lymphoma
96% match

Radiotherapy for Hodgkin Lymphoma

Springer

£62.16 25 Sep 2026
New Trends in the Molecular and Biological Basis for Clinical Oncology
96% match

New Trends in the Molecular and Biological Basis for Clinical Oncology

Springer

£77.89 18 Sep 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
95% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.67 18 Sep 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
95% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£68.68 24 Sep 2026
Hodgkin’s Disease in Children: Controversies and Current Practice: 41 (Cancer Treatment and Research)
95% match

Hodgkin’s Disease in Children: Controversies and Current Practice: 41 (Cancer Treatment and Research)

Springer

£159.18 01 Oct 2026
Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)
95% match

Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Springer

£58.09 03 Oct 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
95% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£88.34 24 Sep 2026
Targeted Therapies in Cancer (Cancer Etiology Diagnosis and Treatments)
95% match

Targeted Therapies in Cancer (Cancer Etiology Diagnosis and Treatments)

Nova Science Publishers Inc

£71.12 17 Sep 2026
Neuro-Oncology & Cancer Targeted Therapy (Cancer Etiology, Diagnosis & Treatments Series)
95% match

Neuro-Oncology & Cancer Targeted Therapy (Cancer Etiology, Diagnosis & Treatments Series)

£107.50 27 Sep 2026
PET/CT in Lymphomas: A Case-Based Atlas
95% match

PET/CT in Lymphomas: A Case-Based Atlas

Springer

£85.16 24 Sep 2026
Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)
95% match

Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)

Springer

£78.11 25 Sep 2026
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
95% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 01 Oct 2026